Brief: Aeterna Zentaris Says Final Results For Study P01 Expected In Q2
28/01/2020 13:31
Jan 28 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS INC - STUDY P01 FINAL STUDY RESULTS
EXPECTED IN
Q2 2020
Source text for Eikon: ID:nGNX8J2KpK
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update